Stockscreener 앱 받기
6.33
2.31%
-0.15
시간 외 거래:
6.10
-0.23
-3.63%
전일 마감가:
$6.48
열려 있는:
$6.32
하루 거래량:
24,914
Relative Volume:
0.41
시가총액:
$16.04M
수익:
-
순이익/손실:
$-11.74M
주가수익비율:
-0.5989
EPS:
-10.5698
순현금흐름:
$-9.50M
1주 성능:
-14.69%
1개월 성능:
-2.91%
6개월 성능:
+1.93%
1년 성능:
-86.67%
1일 변동 폭
$6.10
$6.39
1주일 범위
$6.00
$7.58
52주 변동 폭
$4.6325
$54.50
인텐시티 테라퓨틱스 Stock (INTS) Company Profile
명칭
Intensity Therapeutics Inc
전화
203-221-7381
주소
1 ENTERPRISE DRIVE, SUITE 430, SHELTON
Compare INTS vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INTS
Intensity Therapeutics Inc
|
6.33 | 16.42M | 0 | -11.74M | -9.50M | -10.57 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
인텐시티 테라퓨틱스 주식(INTS)의 최신 뉴스
Forecast Cut: Can Intensity Therapeutics Inc ride the EV waveWeekly Profit Analysis & Technical Entry and Exit Alerts - baoquankhu1.vn
Intensity Therapeutics reports early trial data in breast cancer - Investing.com Nigeria
Intensity Therapeutics updates breast cancer trial, files to resume enrollment following study pause - MSN
Intensity Therapeutics regains Nasdaq compliance By Investing.com - Investing.com Nigeria
Alliance Global Partners Sticks to Their Buy Rating for Intensity Therapeutics, Inc. (INTS) - The Globe and Mail
Intensity Therapeutics Inc (INTS) Stock Price, Quote, News & History - Benzinga
Intensity Therapeutics price target adjusted to $30 at Alliance Global - TipRanks
Intensity Therapeutics Updates Breast Cancer Trial, Files To Resume Enrollment Following Study Pause - Sahm
Intensity Therapeutics reports early trial data in breast cancer By Investing.com - Investing.com Australia
Intensity Therapeutics provides update on INVINCIBLE-4 Study - TipRanks
Ballard Reports Q4 2025 and Full Year Results - Weekly Voice
Intensity Therapeutics, Inc. Provides Update on the Phase 2 Presurgical Triple-Negative Breast Cancer INVINCIBLE-4 Study - ChartMill
INTS Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
INTS Stock Price, Quote & Chart | INTENSITY THERAPEUTICS INC (NASDAQ:INTS) - ChartMill
Bear Alert: Is Intensity Therapeutics Inc likely to announce a buyback2026 Intraday Action & Growth Focused Investment Plans - baoquankhu1.vn
Take Profit: Should I set a stop loss on Intensity Therapeutics Inc2026 Outlook & Safe Entry Point Identification - baoquankhu1.vn
Intensity Therapeutics Regains Nasdaq Compliance, Stabilizing Market Listing - The Globe and Mail
Investment Review: Can Intensity Therapeutics Inc disrupt its industryQuarterly Earnings Report & Daily Oversold Bounce Ideas - baoquankhu1.vn
What's going on with Intensity Therapeutics stock Friday? - MSN
CT biotech firm regains Nasdaq compliance after carrying out reverse-stock split - Hartford Business Journal
Intensity Therapeutics regains compliance with Nasdaq's minimum bid price requirement - marketscreener.com
Intensity Therapeutics Regains Nasdaq $1.00 Minimum Bid Price Compliance - TradingView
Intensity Therapeutics regains Nasdaq compliance - TipRanks
Intensity Therapeutics Regains Compliance with Nasdaq's Minimum Bid Price Requirement - PR Newswire
Why Is Retail Going Gaga Over INTS Stocks Today? - Stocktwits
Intensity Therapeutics (INTS) posts updated preliminary financial highlights slide - Stock Titan
INTS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Intensity Therapeutics Announces Reverse Stock Split - 富途牛牛
Swing Trade: Whats next for Intensity Therapeutics Inc stockPortfolio Return Summary & Verified Chart Pattern Signals - baoquankhu1.vn
Retail Trends: Is Intensity Therapeutics Inc stock influenced by commodity pricesJuly 2025 Setups & Daily Profit Focused Screening - baoquankhu1.vn
INTS.O Technical Analysis & Stock Price Forecast - Intellectia AI
VTVT Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
INTS Should I Buy - Intellectia AI
INTS.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
INTS.O Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
INTS.O PE Ratio & Valuation, Is INTS.O Overvalued - Intellectia AI
Intensity Therapeutics (INTS) Price Target Increased by 2,399.98% to 74.38 - Nasdaq
Surprises Report: Whats next for Intensity Therapeutics Inc stock2025 Retail Activity & Free Community Consensus Stock Picks - baoquankhu1.vn
Aug Mood: Is Intensity Therapeutics Inc stock forming a cup and handleJuly 2025 Summary & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Buy Signal: Should I set a stop loss on Intensity Therapeutics IncJuly 2025 Earnings & Accurate Buy Signal Alerts - baoquankhu1.vn
Sentiment Watch: Can MAAS deliver alphaWeekly Risk Summary & Weekly High Potential Alerts - baoquankhu1.vn
Intensity Therapeutics Inc Share Price USD0.0001 - Hargreaves Lansdown
How Intensity Therapeutics Inc. stock compares to market leadersJuly 2025 Pullbacks & Fast Gain Swing Trade Alerts - mfd.ru
Can Intensity Therapeutics Inc. stock beat market expectations this quarterWeekly Trade Analysis & Low Risk Investment Opportunities - mfd.ru
Is Intensity Therapeutics Inc.’s growth already priced inQuarterly Market Review & AI Enhanced Trading Signals - mfd.ru
Why did INTS stock plummet 25% today? - MSN
Why did INTS stock plummet 30% pre-market today? - MSN
CT biotech firm plans reverse stock split to regain Nasdaq compliance - Hartford Business Journal
Intensity Therapeutics Highlights 2025 Milestones and Outlines 2026 Strategic Priorities - Weekly Voice
Dow Jumps Over 1,000 Points; Tesla Shares Rise After Q1 Results - Intellectia AI
Can Intensity Therapeutics Inc. disrupt its industryPortfolio Risk Report & Free Community Consensus Stock Picks - mfd.ru
인텐시티 테라퓨틱스 (INTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):